Emerson Electric Statistics
Total Valuation
EMR has a market cap or net worth of $66.18 billion. The enterprise value is $74.63 billion.
| Market Cap | 66.18B |
| Enterprise Value | 74.63B |
Important Dates
The next confirmed earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | May 16, 2024 |
Share Statistics
EMR has 572.10 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Shares Outstanding | 572.10M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 77.86% |
| Float | 569.25M |
Valuation Ratios
The trailing PE ratio is 6.18 and the forward PE ratio is 19.99. EMR's PEG ratio is 2.30.
| PE Ratio | 6.18 |
| Forward PE | 19.99 |
| PS Ratio | 4.00 |
| Forward PS | 3.65 |
| PB Ratio | 3.17 |
| P/FCF Ratio | 72.89 |
| PEG Ratio | 2.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.89, with an EV/FCF ratio of 82.19.
| EV / Earnings | 6.95 |
| EV / Sales | 4.52 |
| EV / EBITDA | 5.89 |
| EV / EBIT | 6.61 |
| EV / FCF | 82.19 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.18 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 11.86 |
| Interest Coverage | 332.24 |
Financial Efficiency
Return on equity (ROE) is 51.90% and return on invested capital (ROIC) is 6.46%.
| Return on Equity (ROE) | 51.90% |
| Return on Assets (ROA) | 23.90% |
| Return on Capital (ROIC) | 6.46% |
| Revenue Per Employee | $246,701 |
| Profits Per Employee | $160,284 |
| Employee Count | 67,000 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 3.79 |
Taxes
In the past 12 months, EMR has paid $523.00 million in taxes.
| Income Tax | 523.00M |
| Effective Tax Rate | 4.64% |
Stock Price Statistics
The stock price has increased by +26.19% in the last 52 weeks. The beta is 1.32, so EMR's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | +26.19% |
| 50-Day Moving Average | 111.25 |
| 200-Day Moving Average | 102.43 |
| Relative Strength Index (RSI) | 60.45 |
| Average Volume (20 Days) | 2,503,192 |
Short Selling Information
The latest short interest is 7.01 million, so 1.23% of the outstanding shares have been sold short.
| Short Interest | 7.01M |
| Short Previous Month | 6.41M |
| Short % of Shares Out | 1.23% |
| Short % of Float | 1.23% |
| Short Ratio (days to cover) | 2.83 |
Income Statement
In the last 12 months, EMR had revenue of $16.53 billion and earned $10.74 billion in profits. Earnings per share was $18.72.
| Revenue | 16.53B |
| Gross Profit | 8.21B |
| Operating Income | 2.15B |
| Pretax Income | 11.26B |
| Net Income | 10.74B |
| EBITDA | 12.67B |
| EBIT | 11.30B |
| Earnings Per Share (EPS) | $18.72 |
Balance Sheet
The company has $2.32 billion in cash and $10.77 billion in debt, giving a net cash position of -$8.45 billion or -$14.77 per share.
| Cash & Cash Equivalents | 2.32B |
| Total Debt | 10.77B |
| Net Cash | -8.45B |
| Net Cash Per Share | -$14.77 |
| Equity (Book Value) | 20.90B |
| Book Value Per Share | 36.53 |
| Working Capital | 1.35B |
Cash Flow
In the last 12 months, operating cash flow was $1.31 billion and capital expenditures -$401.00 million, giving a free cash flow of $908.00 million.
| Operating Cash Flow | 1.31B |
| Capital Expenditures | -401.00M |
| Free Cash Flow | 908.00M |
| FCF Per Share | $1.59 |
Margins
Gross margin is 49.65%, with operating and profit margins of 12.99% and 64.97%.
| Gross Margin | 49.65% |
| Operating Margin | 12.99% |
| Pretax Margin | 68.13% |
| Profit Margin | 64.97% |
| EBITDA Margin | 76.65% |
| EBIT Margin | 68.34% |
| FCF Margin | 5.49% |
Dividends & Yields
This stock pays an annual dividend of $2.10, which amounts to a dividend yield of 1.82%.
| Dividend Per Share | $2.10 |
| Dividend Yield | 1.82% |
| Dividend Growth (YoY) | 0.96% |
| Years of Dividend Growth | 67 |
| Payout Ratio | 11.22% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 1.73% |
| Earnings Yield | 16.23% |
| FCF Yield | 1.37% |
Analyst Forecast
The average price target for EMR is $123.44, which is 6.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $123.44 |
| Price Target Difference | 6.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 8.28% |
| EPS Growth Forecast (5Y) | -19.90% |
Stock Splits
The last stock split was on December 12, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 12, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
EMR has an Altman Z-Score of 4.42 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.42 |
| Piotroski F-Score | 5 |